Skip to main content
. 2020 Jan 10;12(1):177. doi: 10.3390/cancers12010177

Table 3.

cDNA Microarray analysis in the field of vestibular schwannoma research.

Methods No of Tumor Samples No and Type of Control Samples Author, Year
cDNA Microarray, RT-PCR 31 CYS-VS
6 SPO-VS
No [45]
cDNA Microarray, Cell cultures, Western Blotting 36 SPO-VS
13 NF2-VS
7 vestibular nerves [39]
cDNA Microarray, RT-PCR, MLPA analysis of NF2 LOH analysis 28 SPO-VS
3 NF2-VS
2 auricular nerves
2 cervical nerves
1 facial nerve
1 vestibular nerve
1 nerve from the VIII cranial pair
1 commercial normal human adult Schwann cell (HSC) RNA
[48]
cDNA Microarray, RT-PCR, IHC 15 SPO-VS
7 CYS-VS
3 RAD-VS
3 tibial nerves [33]
cDNA Microarray, RT-PCR, IHC 13 VS No [46]
cDNA Microarray 16 SPO-VS 3 vestibular nerves [34]
cDNA Microarray, RT-PCR 11 SPO-VS 11 blood samples [47]
cDNA Microarray, RT-PCR, IHC 3 SPO-VS
1 CYS-VS
3 RAD-VS
1 vestibular nerve [26]
cDNA Microarray, IHC 36 SPO-VS
13 NF2-VS
9 CYS-VS
9 RAD-VS
7 vestibular nerves Current study

cDNA: complementary DNA; CYS-VS: cystic vestibular schwannoma; IHC: immunohistochemistry; LOH: loss of heterozygosity; MLPA: multiplex ligation-dependent probe amplification; NF2-VS: neurofibromatosis type 2-associated vestibular schwannoma; RAD-VS: irradiated vestibular schwannoma; RT-PCR: real-time polymerase chain reaction; SPO-VS: sporadic vestibular schwannoma.